MEDIROM Healthcare Technologies EBITDA 2021-2024 | MRM

MEDIROM Healthcare Technologies ebitda from 2021 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
MEDIROM Healthcare Technologies Annual EBITDA
(Millions of US $)
2023 $-1
2022 $2
2021 $-3
2020 $-6
2019 $
MEDIROM Healthcare Technologies Quarterly EBITDA
(Millions of US $)
2023-12-31
2023-06-30
2022-12-31
2022-06-30
2021-12-31
2021-06-30
2020-12-31
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.004B $0.049B
MEDIROM Healthcare Technologies Inc. is a holistic healthcare company. MEDIROM Healthcare Technologies Inc. is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $21.703B 0.00
Quest Diagnostics (DGX) United States $17.349B 17.58
DaVita (DVA) United States $14.249B 18.43
Encompass Health (EHC) United States $9.629B 22.70
Chemed (CHE) United States $8.394B 25.80
Elanco Animal Health (ELAN) United States $6.076B 14.46
Option Care Health (OPCH) United States $5.267B 24.96
RadNet (RDNT) United States $4.972B 110.11
LifeStance Health (LFST) United States $3.092B 0.00
Amedisys (AMED) United States $3.023B 21.51
Addus HomeCare (ADUS) United States $2.290B 26.87
Astrana Health (ASTH) United States $2.076B 28.39
U.S Physical Therapy (USPH) United States $1.337B 35.14
Pennant (PNTG) United States $0.945B 38.21
Aveanna Healthcare Holdings (AVAH) United States $0.945B 0.00
Atai Life Sciences (ATAI) Germany $0.252B 0.00
Bioqual (BIOQ) United States $0.055B 0.00
Daxor (DXR) United States $0.038B 0.00
Ontrak (OTRK) United States $0.007B 0.00
IMAC Holdings (BACK) United States $0.002B 0.00
Psychemedics (PMD) United States $0.000B 0.00